179 related articles for article (PubMed ID: 1854174)
1. In vitro evaluation of GR69153, a novel catechol-substituted cephalosporin.
Erwin ME; Jones RN; Barrett MS; Briggs BM; Johnson DM
Antimicrob Agents Chemother; 1991 May; 35(5):929-37. PubMed ID: 1854174
[TBL] [Abstract][Full Text] [Related]
2. In vitro comparison of GR69153, a novel catechol-substituted cephalosporin, with ceftazidime and ceftriaxone against 5,203 recent clinical isolates.
Washington JA; Jones RN; Allen SD; Gerlach EH; Koontz FP; Murray PR; Pfaller MA; Erwin ME
Antimicrob Agents Chemother; 1991 Jul; 35(7):1508-11. PubMed ID: 1929319
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of a catechol-substituted cephalosporin, GR69153.
Wise R; Andrews JM; Ashby JP; Thornber D
Antimicrob Agents Chemother; 1991 Feb; 35(2):329-34. PubMed ID: 2024966
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity and beta-lactamase stability of GR69153, a new long-acting cephalosporin.
Chin NX; Gu JW; Fang W; Neu HC
Antimicrob Agents Chemother; 1991 Feb; 35(2):259-66. PubMed ID: 2024959
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activity of E-1040, a novel thiadiazolyl cephalosporin compared with other parenteral cephems.
Jones RN; Erwin ME; Barrett MS; Johnson DM; Briggs BM
Diagn Microbiol Infect Dis; 1991; 14(4):301-9. PubMed ID: 1889181
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of the novel cephalosporin GR69153.
Clarke AM; Zemcov SJ
Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):683-7. PubMed ID: 1748126
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity evaluations of cefdinir (FK482, CI-983, and PD134393). A novel orally administered cephalosporin.
Briggs BM; Jones RN; Erwin ME; Barrett MS; Johnson DM
Diagn Microbiol Infect Dis; 1991; 14(5):425-34. PubMed ID: 1797457
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
Nishino T; Otsuki M; Hatano K; Nishihara Y
Chemotherapy; 1994; 40(3):167-82. PubMed ID: 8205935
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of Ro 09-1227, a novel catechol-substituted cephalosporin.
Jones RN; Erwin ME
Antimicrob Agents Chemother; 1992 Jan; 36(1):233-8. PubMed ID: 1590695
[TBL] [Abstract][Full Text] [Related]
10. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Jones RN; Sader HS; Fritsche TR; Pottumarthy S
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of a new cephalosporin ME-1206 compared with other agents.
Chin NX; Zhang YX; Neu HC
Diagn Microbiol Infect Dis; 1991; 14(5):417-24. PubMed ID: 1797456
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of Ro 09-1428 compared to other cephalosporins.
Chin NX; Gu JW; Fang W; Neu HC
Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):669-75. PubMed ID: 1748124
[TBL] [Abstract][Full Text] [Related]
13. Cefquinome (HR 111V). In vitro evaluation of a broad-spectrum cephalosporin indicated for infections in animals.
Murphy SP; Erwin ME; Jones RN
Diagn Microbiol Infect Dis; 1994 Sep; 20(1):49-55. PubMed ID: 7867299
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of E-1040, a novel cephalosporin with potent activity against Pseudomonas aeruginosa.
Neu HC; Chin NX; Novelli A
Antimicrob Agents Chemother; 1988 Nov; 32(11):1666-75. PubMed ID: 3150915
[TBL] [Abstract][Full Text] [Related]
15. [In vitro antimicrobial activity of cefpirome compared to other broad-spectrum beta-lactam drugs against 804 clinical isolates from 9 Brazilian hospitals].
Sader HS; Mendes CM; Montelli A; Sampaio J; Segura AJ; Kesselring GL; Costa L; Ribeiro JE; Mamizuka E; Mimiça I
Rev Assoc Med Bras (1992); 1998; 44(4):283-8. PubMed ID: 9852647
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial activity of FK-037, a new broad-spectrum cephalosporin. International in vitro comparison with cefepime and ceftazidime.
Frei R; Jones RN; Pignatari AC; Yamane N; Marco F; Hoban DJ
Diagn Microbiol Infect Dis; 1994 Mar; 18(3):167-73. PubMed ID: 7924209
[TBL] [Abstract][Full Text] [Related]
17. The antimicrobial activity and beta-lactamase stability of cefpirome, a new fourth-generation cephalosporin in comparison with other agents.
Cheng AF; Ling TK; Lam AW; Fung KS; Wise R
J Antimicrob Chemother; 1993 May; 31(5):699-709. PubMed ID: 8335498
[TBL] [Abstract][Full Text] [Related]
18. In vitro antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin.
Mine Y; Watanabe Y; Sakamoto H; Hatano K; Kuno K; Higashi Y; Kamimura T; Matsumoto Y; Tawara S; Matsumoto F
J Antibiot (Tokyo); 1993 Jan; 46(1):71-87. PubMed ID: 8436562
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial activity of a new antipseudomonal dual-action drug, Ro 25-0534.
Jones RN; Sanchez ML
Diagn Microbiol Infect Dis; 1994 Jan; 18(1):61-8. PubMed ID: 8026159
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group.
Yamaguchi K; Mathai D; Biedenbach DJ; Lewis MT; Gales AC; Jones RN
Diagn Microbiol Infect Dis; 1999 Jun; 34(2):123-34. PubMed ID: 10354863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
